The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Disturbing Dream and Nightmare Severity Index (DDNSI)
Timeframe: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks)
Nightmare frequency (sleep diary)
Timeframe: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks)